
Sign up to save your podcasts
Or


Marcus Schindler, chief scientific officer, and head of research and early development at Novo Nordisk, shares the ways in which he's leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress with McKinsey colleagues Alex Devereson and Nav Nagra.
Learn more about the McKinsey R&D practice here.
See www.mckinsey.com/privacy-policy for privacy information
From the publisher's feed
McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

334 Listeners